Navigation Links
Kaiser Permanente Honored for Success in Diabetes and Heart Disease Prevention
Date:11/5/2008

California Department of Managed Health Care recognizes health care

organization with first-ever Director's Right Care Award

OAKLAND, Calif., Nov. 5 /PRNewswire/ -- The California Department of Managed Health Care has honored Kaiser Permanente with the "Director's Right Care Initiative Award" for its outstanding work in diabetes and heart disease prevention. This is the inaugural presentation of the award and is part of the DMHC's "Right Care Initiative," which examines managed care and the quality of service provided to California's citizens.

"We are honored that the DMHC has recognized the quality initiatives we have in place to ensure optimal health for our members," said Jeffrey Weisz, MD, executive medical director of the Southern California Permanente Medical Group. "Kaiser Permanente's focus has always been on keeping patients healthy and getting them well when they are not, and this award further underscores that ongoing commitment."

The award is based on measurements from the Healthcare Effectiveness Data and Information Set, a standard used by more than 90 percent of America's health plans to measure performance on important dimensions of care and service. Kaiser Permanente was selected for this award based on its scores that ranked it at or near the 90th percentile for critical HEDIS life-saving control measures.

"This award reflects our remarkable accomplishments at Kaiser Permanente, and explains why our patients have a 30 percent lower risk of dying from cardiovascular disease compared to the non-Kaiser population of Northern California," said Robert Pearl, MD, executive director and CEO of The Permanente Medical Group, whose 7,000 physicians provide health care to Kaiser Permanente's 3.3 million members in Northern California.

Kaiser Permanente Northern California was recognized for critical HEDIS life-saving control measures in controlling high blood pressure, screening and controlling high choles
'/>"/>

SOURCE Kaiser Permanente
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results
2. Kaiser Family Foundation to Launch Non-Profit Health Policy News Service
3. Kaiser Permanente Approves $12 Million in Community Benefit Grants in Third Quarter of 2008
4. Kaiser Permanente and Veterans Affairs Preview Electronic Health Record Interoperability to Enable Better Health Care
5. Losing Weight After Diabetes Diagnosis can Prevent Diabetes-Related Disease, Kaiser Permanente Study Finds
6. Kaiser Permanente - Stanford Heart Research Center Funded to Study Treatment Outcomes
7. Kaiser Permanente Becomes Presenting Sponsor for Pasadena Marathon
8. J.D. Power and Associates Study Ranks Kaiser Permanente Highest in Member Satisfaction in South Atlantic Region
9. Gold Medalist Jennie Finch & Relationship Expert Stacy Kaiser Help Wired Couples Unplug
10. Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008
11. Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Fla. (PRWEB) , ... September 01, 2015 , ... Elizabeth ... be one of the first in the area to offer RADIESSE® filler treatment for ... to reduce the prominence of tendons and veins in the hands, delivering smooth, natural-looking ...
(Date:9/1/2015)... IL (PRWEB) , ... September 01, 2015 , ... ... and Zeel™, has recently sponsored an educational workshop for physician assistants (PAs) practicing ... Injections of Traumeel™ and Zeel™” was held by Dr. Erick Salado, an orthopedic ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... a leading retailer of professional hair salons. This highly anticipated partnership between Curly ... the Curl Keeper™ Styling Collection. Founder Jonathan Torch and the Curly Hair Solutions™ ...
(Date:8/31/2015)... ... August 31, 2015 , ... Jvion, the Atlanta-based ... predictive use case focused on helping hospital perform under the Center for Medicare ... payments are adjusted based on performance across four domains related to care quality. ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental clinicians from ... of Health Sciences to learn more about its integrated approach to diabetes care. ... and Institute of Cellular Medicine at Newcastle University, and Susan Bissett, National Institute ...
Breaking Medicine News(10 mins):Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4
... Too much or too little of the hormone, though, can be ... has long been implicated as being heart protective in premenopausal women, ... of estrogen might be helpful for men as well. , ... of the American Medical Association , found that men with heart ...
... Alexander, it,s meant orthotics and physical therapy so he ... it,s an insulin pump for her Type 1 Diabetes. ... it,s a wheelchair.All these children and more than a ... Children,s Foundation (UHCCF) in recent years to help pay ...
... 12 The YWCA USA Annual General Assembly elected new officers ... Coordinating Board, during its recent 2009 National Conference in Washington, D.C.New ... Chair: Debra Stock, Executive Director of YWCA York, ... Jeanette Castellanos-Butt, Associate Director of YWCA Greater Chicago, Illinois , ...
... SAP Partner ,Ecosystem,FALLS CHURCH, Va., May 12 ... that it has been awarded an SAP Global Pinnacle ... The company also was recognized as a finalist in ... a ceremony on May 11, the eve of SAPPHIRE, ...
... author Philip Leitman draws from personal experience with ... in two Canadian provincesMIAMI , May 12 ... Ros-Lehtinen (R-FL) and a Democratic constituent in her ... health care reform in America in a personal ...
... LL C has ... In her new role, DeMatteo will guide the development ... activities founded on proven learning adult principles, delivered through ... CME LLC more than ...
Cached Medicine News:Health News:Estrogen May Help Men's Hearts 2Health News:Estrogen May Help Men's Hearts 3Health News:UnitedHealthcare Children's Foundation To Award More Medical Grants for Child Health Care Needs in New Jersey 2Health News:YWCA USA Elects New National Leadership Team 2Health News:CSC Receives SAP Pinnacle Award for Global IT Outsourcing 2Health News:Florida Congresswoman Sends to Every Member of Senate Canadian-born U.S. Citizen's Prescription for Health Care Reform 2Health News:Ann Marie DeMatteo Joins CME LLC as Vice President of Educational Initiatives, Drives Innovative Programming Approaches 2
(Date:8/31/2015)... Aug. 31, 2015  Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today it has completed enrollment of the ... Committee (DRC) earlier this year, into the company,s ... first-in-class innate defense regulator (IDR) and is being ...
(Date:8/31/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the third ... -based Rush University Medical Center in a ... doses of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... spinal cord injury (SCI). This represents the final ...
(Date:8/31/2015)... N.J. and STAMFORD, Conn. ... pharmaceutical subsidiary of Eisai Co., Ltd., and Purdue Pharma ... worldwide collaboration agreement for the development and commercialization of ... orexin receptor antagonist entering Phase III clinical development for ... terms of the agreement, Eisai and Purdue Pharma will ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5
... , HELSINKI, Dec. 14 Cancer ... with the introduction of RapidArc® radiotherapy technology from Varian Medical ... radiotherapy clinic in the Nordic region. Clinicians at Docrates Clinic ... radiotherapy to treat patients with multiple brain metastases and cancers ...
... , WALTHAM, Mass., Dec. ... authority on medical technology market intelligence, increased use of safety ... be a key driver of the enteral feeding device markets ... and European Markets for Enteral Feeding Devices 2010 report ...
Cached Medicine Technology:Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3
... designed for PCR amplification and target ... systems. The NGEN product line includes ... associated with cystic fibrosis, thrombosis, and ... for the detection of sequences associated ...
... pregnancy testing, our new ICON 25 hCG ... you fast, accurate results, plus Beckman Coulter ... hCG offers CLIA waived simplicity for urine ... For the hospital, it's the perfect complement ...
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Medicine Products: